These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34445268)

  • 21. Durability of Sirolimus for Lymphangioleiomyomatosis.
    Martirossian A; Shah S; Carrete L; Valle J; Valentine V
    Am J Med Sci; 2017 Dec; 354(6):603-607. PubMed ID: 29208258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.
    Taveira-DaSilva AM; Hathaway O; Stylianou M; Moss J
    Ann Intern Med; 2011 Jun; 154(12):797-805, W-292-3. PubMed ID: 21690594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SUCCESSFUL TREATMENT OF PULMONARY AND LYMPHATIC MANIFESTATIONS OF LYMPHANGIOLEIOMYOMATOSIS WITH SIROLIMUS.
    Hecimovic A; Jakopovic M; Pavlisa G; Jankovic M; Vukic-Dugac A; Redzepi G; Brcic L; Samarzija M; Gupta N
    Lymphology; 2015 Jun; 48(2):97-102. PubMed ID: 26714374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study.
    Kim C; Do KH; Cha J; Song JW; Lee SM; Lee KY
    Eur Radiol; 2020 Feb; 30(2):735-743. PubMed ID: 31471750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
    Hayashi T; Kumasaka T; Mitani K; Okada Y; Kondo T; Date H; Chen F; Oto T; Miyoshi S; Shiraishi T; Iwasaki A; Hara K; Saito T; Ando K; Kobayashi E; Gunji-Niitsu Y; Kunogi M; Takahashi K; Yao T; Seyama K
    Hum Pathol; 2016 Apr; 50():34-42. PubMed ID: 26997436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis.
    Gopalakrishnan V; Yao J; Steagall WK; Avila NA; Taveira-DaSilva AM; Stylianou M; Chen MY; Moss J
    Chest; 2019 May; 155(5):962-971. PubMed ID: 30660784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A rare cause of edema: sporadic lymphangioleiomyomatosis].
    Frank H; Weiss W
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1892-5. PubMed ID: 24022453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration.
    Chebib N; Archer F; Bobet-Erny A; Leroux C; Cottin V
    Sci Rep; 2018 Oct; 8(1):14698. PubMed ID: 30279475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of mTOR inhibitors on the mortality and safety of patients with lymphangioleiomyomatosis on the lung transplantation waitlist: A retrospective cohort study.
    Sakurai T; Kanou T; Funaki S; Fukui E; Kimura T; Ose N; Inoue Y; Shintani Y
    Respir Investig; 2024 Jul; 62(4):657-662. PubMed ID: 38761480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sporadic Lymphangioleiomyomatosis Disease: A Case Report.
    Nikmanesh Y; Shokripour M; Mokhtari M; Khazayi M; Monabati A; Rezayi R; Bahtouee M
    Iran J Med Sci; 2023 Sep; 48(5):516-521. PubMed ID: 37786468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis.
    Ando K; Fujino N; Mitani K; Ota C; Okada Y; Kondo T; Mizobuchi T; Kurihara M; Suzuki K; Hoshika Y; Ebana H; Kobayashi E; Takahashi K; Kubo H; Seyama K
    Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(10):L899-908. PubMed ID: 27016587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of sirolimus in lymphangioleiomyomatosis.
    McCormack FX; Inoue Y; Moss J; Singer LG; Strange C; Nakata K; Barker AF; Chapman JT; Brantly ML; Stocks JM; Brown KK; Lynch JP; Goldberg HJ; Young LR; Kinder BW; Downey GP; Sullivan EJ; Colby TV; McKay RT; Cohen MM; Korbee L; Taveira-DaSilva AM; Lee HS; Krischer JP; Trapnell BC; ;
    N Engl J Med; 2011 Apr; 364(17):1595-606. PubMed ID: 21410393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation.
    Zaki KS; Aryan Z; Mehta AC; Akindipe O; Budev M
    World J Transplant; 2016 Mar; 6(1):249-54. PubMed ID: 27011924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: Role for tumor suppressor TSC2.
    Goncharova EA; Goncharov DA; Spaits M; Noonan DJ; Talovskaya E; Eszterhas A; Krymskaya VP
    Am J Respir Cell Mol Biol; 2006 May; 34(5):561-72. PubMed ID: 16424383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM).
    Goncharova EA; Goncharov DA; Eszterhas A; Hunter DS; Glassberg MK; Yeung RS; Walker CL; Noonan D; Kwiatkowski DJ; Chou MM; Panettieri RA; Krymskaya VP
    J Biol Chem; 2002 Aug; 277(34):30958-67. PubMed ID: 12045200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta 1 and extracellular matrix-associated fibronectin expression in pulmonary lymphangioleiomyomatosis.
    Evans SE; Colby TV; Ryu JH; Limper AH
    Chest; 2004 Mar; 125(3):1063-70. PubMed ID: 15006970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis.
    Flavin RJ; Cook J; Fiorentino M; Bailey D; Brown M; Loda MF
    Am J Clin Pathol; 2011 May; 135(5):776-82. PubMed ID: 21502434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis.
    Wang Q; Luo M; Xiang B; Chen S; Ji Y
    Respir Res; 2020 Feb; 21(1):55. PubMed ID: 32059669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current understanding and perspectives of lymphangioleiomyomatosis].
    Seyama K; Ando K; Hoshika Y; Suzuki Y; Takekawa H
    Nihon Rinsho; 2013 Jun; 71(6):1103-8. PubMed ID: 23855221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis.
    Matsumoto Y; Horiba K; Usuki J; Chu SC; Ferrans VJ; Moss J
    Am J Respir Cell Mol Biol; 1999 Sep; 21(3):327-36. PubMed ID: 10460750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.